Veeva Systems (VEEV)
(Delayed Data from NYSE)
$217.02 USD
+17.67 (8.86%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $217.51 +0.49 (0.23%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$217.02 USD
+17.67 (8.86%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $217.51 +0.49 (0.23%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum A VGM
Zacks News
Factors to Note Ahead of NetApp's (NTAP) Q4 Earnings Release
by Zacks Equity Research
NetApp's (NTAP) fiscal fourth-quarter performance is likely to reflect strength in the Public Cloud Services and all-flash storage business
NextGen Healthcare (NXGN) Unveils Health Data Hub Insights
by Zacks Equity Research
NextGen Healthcare's (NXGN) newly launched tool can help healthcare providers to receive a complete picture of the community and patient health.
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Merit Medical (MMSI) due to its strong product portfolio.
Veeva Systems (VEEV) Vault CTMS to Aid Clinical Trial Management
by Zacks Equity Research
Veeva System's (VEEV) Vault CTMS to streamline complex trial processes for more than 150 companies.
Digital Turbine (APPS) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Digital Turbine's (APPS) fourth-quarter 2022 earnings are expected to have benefited from the solid performance of the content media and fyber business.
Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
Abbott (ABT) to Commence Limited Release of EleCare Soon
by Zacks Equity Research
Abbott's (ABT) release of limited quantities of EleCare branded specialty formulas to be free of charge to children in need.
Pinduoduo (PDD) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Pinduoduo's (PDD) first-quarter results are expected to reflect online marketing services' strength. However, uncertainties related to the pandemic are likely to have acted as a headwind.
Box (BOX) Q1 Earnings Lag Estimates
by Zacks Equity Research
Box (BOX) delivered earnings and revenue surprises of -8% and 1.81%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Veeva (VEEV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Must Add Masimo (MASI) Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Masimo's (MASI) PVi Favored by New Study for Pediatric Patients
by Zacks Equity Research
Masimo's (MASI) PVi is expected to take better treatment decisions for pediatric patients with signs of obstructive respiratory disease in the EDs.
NextGen Healthcare's (NXGN) Solutions Selected by MHHC
by Zacks Equity Research
NextGen Healthcare's (NXGN) solutions get chosen by MHHC that can help serve the latter's rapidly growing community efficiently.
Veeva Systems (VEEV) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect a solid show by its segments and robust product portfolio.
The Zacks Analyst Blog Highlights 8x8, Duck Creek Technologies, Paycom Software and Veeva Systems
by Zacks Equity Research
8x8, Duck Creek Technologies, Paycom Software and Veeva Systems have been included in this Analyst Blog.
Shockwave Medical's (SWAV) IVL Cleared for Use in China
by Zacks Equity Research
Shockwave Medical's (SWAV) latest regulatory approval is expected to serve a wider patient pool.
Here's Why You Should Retain Change Healthcare (CHNG) Stock
by Zacks Equity Research
Change Healthcare (CHNG) continues to benefit from strategic deals. However, intense competition remains a woe.
Baidu (BIDU) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Baidu's (BIDU) first-quarter results are expected to reflect the AI business's strength and gains from expanding autonomous driving efforts.
Dell Technologies (DELL) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Dell Technologies' (DELL) first-quarter fiscal 2023 performance is expected to reflect strong PC sales and solid growth in servers amid supply-chain constraints and higher component costs.
4 Stocks to Buy on Surge in Cloud Infrastructure Spending
by Ritujay Ghosh
A rapid rise in spending on cloud infrastructure services is helping companies like 8x8, Inc. (EGHT), Duck Creek Technologies, Inc. (DCT), Paycom Software, Inc. (PAYC) and Veeva Systems Inc. (VEEV).
VMware (VMW) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
VMware's (VMW) first-quarter fiscal 2023 performance is likely to have benefited from a strong portfolio and an expanding partner base.
BOX Gears Up to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
BOX's first-quarter fiscal 2023 results are likely to reflect gains from the growing adoption of content cloud solutions. Also, growing efforts toward product innovation might have been a tailwind.
What's in the Cards for Agilent Technologies' (A) Q2 Earnings?
by Zacks Equity Research
Agilent Technologies' (A) fiscal second-quarter results are expected to reflect portfolio strength and momentum across all segments.
PerkinElmer (PKI) Boosts Genomic Testing Portfolio With urWGS
by Zacks Equity Research
PerkinElmer's (PKI) urWGS will improve outcomes for critically ill patients in NICUs and PICUs.
Can Veeva (VEEV) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Veeva (VEEV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.